Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deoxycholic acid enhancement of lymphocyte migration through direct interaction with the intestinal vascular endothelium.
Shibuya N, Higashiyama M, Akita Y, Shirakabe K, Ito S, Nishii S, Mizoguchi A, Inaba K, Tanemoto R, Sugihara N, Hanawa Y, Wada A, Horiuchi K, Yoshikawa K, Kurihara C, Okada Y, Watanabe C, Komoto S, Tomita K, Saruta M, Hokari R. Shibuya N, et al. J Gastroenterol Hepatol. 2021 Sep;36(9):2523-2530. doi: 10.1111/jgh.15509. Epub 2021 Apr 14. J Gastroenterol Hepatol. 2021. PMID: 33783040
Correction: Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study.
Miyazaki R, Sakurai T, Shimada M, Iwashita Y, Shibuya N, Akita Y, Miyashita H, Maruyama Y, Saruta M. Miyazaki R, et al. Among authors: shibuya n. BMC Gastroenterol. 2022 Aug 25;22(1):397. doi: 10.1186/s12876-022-02445-0. BMC Gastroenterol. 2022. PMID: 36008754 Free PMC article. No abstract available.
Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis.
Naganuma M, Kobayashi T, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Abe T, Hisamatsu T; Japanese UC Study Group. Naganuma M, et al. J Gastroenterol. 2023 Dec;58(12):1198-1210. doi: 10.1007/s00535-023-02048-w. Epub 2023 Oct 13. J Gastroenterol. 2023. PMID: 37831183
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria.
Naganuma M, Nakamura N, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Kobayashi T, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Takagi T, Omori T, Tahara T, Hisamatsu T; Japanese UC Study Group. Naganuma M, et al. J Gastroenterol. 2024 Apr;59(4):302-314. doi: 10.1007/s00535-024-02079-x. Epub 2024 Jan 26. J Gastroenterol. 2024. PMID: 38277006
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: shibuya n. Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38651779
Protective Effect of Luminal Uric Acid Against Indomethacin-Induced Enteropathy: Role of Antioxidant Effect and Gut Microbiota.
Wada A, Higashiyama M, Kurihara C, Ito S, Tanemoto R, Mizoguchi A, Nishii S, Inaba K, Sugihara N, Hanawa Y, Horiuchi K, Shibuya N, Akiyama M, Okada Y, Watanabe C, Komoto S, Tomita K, Takei F, Hokari R. Wada A, et al. Among authors: shibuya n. Dig Dis Sci. 2022 Jan;67(1):121-133. doi: 10.1007/s10620-021-06848-z. Epub 2021 Feb 11. Dig Dis Sci. 2022. PMID: 33569665
462 results